Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes. Reply.
作者信息
Kalyani Rita R
机构信息
Johns Hopkins University School of Medicine, Baltimore, MD
出版信息
N Engl J Med. 2021 Aug 12;385(7):671-672. doi: 10.1056/NEJMc2107340.
PMID:34379941
Abstract
摘要
相似文献
1
Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes. Reply.
N Engl J Med. 2021 Aug 12;385(7):671-672. doi: 10.1056/NEJMc2107340.
2
Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes.
N Engl J Med. 2021 Aug 12;385(7):669-670. doi: 10.1056/NEJMc2107340.
3
Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes.
N Engl J Med. 2021 Aug 12;385(7):670-671. doi: 10.1056/NEJMc2107340.
4
Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes.
N Engl J Med. 2021 Aug 12;385(7):670. doi: 10.1056/NEJMc2107340.
5
[Cardiovascular effects and safety of glucose-lowering drugs: current situation].
Semergen. 2014 Mar;40(2):80-8. doi: 10.1016/j.semerg.2012.12.001. Epub 2013 Feb 4.
6
[Intensive blood glucose lowering to reduce cardiovascular risk: pro].
Dtsch Med Wochenschr. 2009 May;134(20):1060. doi: 10.1055/s-0029-1222568. Epub 2009 May 6.
7
[Intensive blood glucose lowering to reduce cardiovascular risk: contra].
Dtsch Med Wochenschr. 2009 May;134(20):1061. doi: 10.1055/s-0029-1222569. Epub 2009 May 6.
8
Response to "Effects of semaglutide on cardiovascular risk factors and eating behaviors in type 2 diabetes".
Acta Diabetol. 2023 May;60(5):715-716. doi: 10.1007/s00592-023-02061-8. Epub 2023 Mar 11.
9
Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes.
N Engl J Med. 2021 Apr 1;384(13):1248-1260. doi: 10.1056/NEJMcp2000280.
10
A Practical Guide to the Use of Glucose-Lowering Agents With Cardiovascular Benefit or Proven Safety.
Can J Cardiol. 2017 Jul;33(7):940-942. doi: 10.1016/j.cjca.2017.04.012. Epub 2017 May 9.
Zotero 插件